NEW YORK (GenomeWeb) – Molecular diagnostics firm Lineagen today announced the close of the second and final tranche of its Series C financing round that brought in a total of $15.8 million. 

The second tranche raised about $12.2 million and follows a $3.5 million first tranche that the Salt Lake City-based firm raised in December 2013. Lineagen said that it also received a $4 million secured debt facility with Silicon Valley Bank as part of the initial tranche.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.